| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
2e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-07 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-07 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-06 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-05 |